XML 79 R46.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Segment Reporting (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Segment Reporting [Abstract] |
Schedule of Business Segment Information | The Company's business segment information was as follows (in thousands):
| Year Ended December 31, |
| 2024 |  |  | 2023 |  |  | 2022 |
Proteomics segment: |  |  |  |  |  |  |  |
Revenue | $ | 135,789 |  |  | $ | 63,883 |  |  | $ | 52,502 |
Cost of revenue |  | 73,992 |  |  |  | 37,644 |  |  |  | 32,461 |
Operating expenses |  | 123,692 |  |  |  | 47,647 |  |  |  | 47,429 |
Proteomics loss from operations | $ | (61,895 | ) |  | $ | (21,408 | ) |  | $ | (27,388 | )
Genomics segment: |  |  |  |  |  |  |  |
Revenue | $ | 38,643 |  |  | $ | 42,457 |  |  | $ | 45,446 |
Cost of revenue: |  | 16,178 |  |  |  | 18,246 |  |  |  | 28,436 |
Operating expenses |  | 19,267 |  |  |  | 24,317 |  |  |  | 42,622 |
Genomics income (loss) from operations | $ | 3,198 |  |  | $ | (106 | ) |  | $ | (25,612 | )
Total segment loss from operations | $ | (58,697 | ) |  | $ | (21,514 | ) |  | $ | (53,000 | )
Reconciliation of income (loss) from operations: |  |  |  |  |  |  |  |
Corporate expenses |  | 76,060 |  |  |  | 41,525 |  |  |  | 49,616 |
Restructuring and related charges |  | 12,500 |  |  |  | 7,076 |  |  |  | 9,732 |
Transaction and integration expenses |  | 27,979 |  |  |  | 6,485 |  |  |  | 3,857 |
Total loss from operations | $ | (175,236 | ) |  | $ | (76,600 | ) |  | $ | (116,205 | )
Depreciation and amortization: |  |  |  |  |  |  |  |
Proteomics | $ | 9,198 |  |  | $ | 12,072 |  |  | $ | 12,223 |
Genomics |  | 1,486 |  |  |  | 601 |  |  |  | 230 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration